Novotech agrees acquisition of Agilex Biolabs to expand bioanalytical capabilities in Australia
Novotech has agreed to acquire Agilex Biolabs, adding specialist bioanalytical laboratory capabilities to its Australian clinical-development platform.
Agilex provides bioanalytical services supporting early-stage drug development and will broaden Novotech's ability to offer integrated laboratory and clinical services.
The acquisition strengthens Novotech's early-phase infrastructure in Australia and expands the range of services available to biotechnology and pharmaceutical sponsors.
Field | Content |
Article Type | Deals |
Companies | Novotech; Agilex Biolabs |
Deal Type | Acquisition |
Acquired Company | Agilex Biolabs |
Sector | Contract research organisation and bioanalytical services |
Capabilities | Bioanalysis; early-phase drug development support; laboratory services |
Geography | Australia |
What Happened | Novotech agreed to acquire Adelaide-based Agilex Biolabs. |
Why It Matters | The transaction adds specialist bioanalytical laboratory capabilities to Novotech's existing clinical-development infrastructure. |
Supporting Context | Agilex supports pharmaceutical and biotechnology clients with bioanalytical services used during early drug development. |
Strategic Rationale | The acquisition enables Novotech to provide a more integrated clinical and laboratory offering to sponsors. |
Potential Impact | Clients may be able to consolidate more early-phase clinical and bioanalytical work within a single service provider. |
Key Takeaway | Novotech is expanding its Australian early-development platform through the acquisition of Agilex Biolabs. |
What to Watch | Transaction completion, integration of Agilex capabilities and expansion of combined laboratory services. |
Primary Source | Novotech |
Relevant Date | 25 September 2026 |
Discover how nuaxia can support your next medical education initiative:
Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector
Contact us on: support@nuaxia.com
댓글